InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Stakeholders brace for first biosimilar application

Eileen McDermott, Washington DC

Innovator companies and potential biosimilar applicants have expressed reservations about the new US scheme for biosimilar approval, which became law in March last year

Speakers on both sides of the debate discussed their concerns with the Biologics Price Competition and Innovation provision of President Obama’s landmark healthcare legislation during a session held at the BIO International Convention in Washington, DC on Monday.


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

More from the Managing IP blog

null null null

null null null

November / December 2019

IP law: are the pressures taking their toll?

Following World Mental Health Day, Max Walters seeks the views of in-house professionals on whether they struggle with workplace pressures, and asks how to improve wellbeing

Most read articles